Literature DB >> 3090600

Scopolamine and the control of attention in humans.

M P Dunne, L R Hartley.   

Abstract

Recent work with humans and animals has suggested that the cholinergic system plays an important role in the active control of attention. This study was designed to investigate the effects of scopolamine upon subjects' ability to utilize knowledge of the spatial probability bias in a display in the detection of briefly-presented target letters. Results showed a significant interaction between drug condition (scopolamine 0.9 mg versus Placebo) and target location probability, which indicated that detection of targets in high probability locations decreased under the drug, while detection in low probability locations increased. These results offer support for the notion that scopolamine reduces the efficiency of information encoding because it impairs the optimal utilization of attentional resources.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090600     DOI: 10.1007/bf00175197

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Optimal allocation of cognitive resources to spatial locations.

Authors:  M L Shaw; P Shaw
Journal:  J Exp Psychol Hum Percept Perform       Date:  1977-05       Impact factor: 3.332

Review 2.  The elderly and the control of simple behaviour by probabilistic information.

Authors:  A J Sanford
Journal:  Gerontology       Date:  1978       Impact factor: 5.140

3.  Human memory and the cholinergic system. A relationship to aging?

Authors:  D A Drachman; J Leavitt
Journal:  Arch Neurol       Date:  1974-02

4.  An interpretation of some conflicting evidence regarding the effects of scopolamine upon vigilance.

Authors:  M P Dunne
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Controlled and automatic information processing in senile dementia: a review.

Authors:  A F Jorm
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

6.  The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis.

Authors:  M P Dunne; L R Hartley
Journal:  Acta Psychol (Amst)       Date:  1985-03

7.  Scopolamine disrupts maintenance of attention rather than memory processes.

Authors:  M L Cheal
Journal:  Behav Neural Biol       Date:  1981-10

8.  The cholinergic system in old age and Alzheimer's disease.

Authors:  E K Perry
Journal:  Age Ageing       Date:  1980-02       Impact factor: 10.668

9.  The separate and combined effects of scopolamine and nicotine on human information processing.

Authors:  K Wesnes; A Revell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

  10 in total
  17 in total

Review 1.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

4.  Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine.

Authors:  J McGaughy; J Turchi; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

5.  Age-related decline in central cholinergic function demonstrated with scopolamine.

Authors:  P N Tariot; S V Patel; C Cox; R E Henderson
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 6.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

7.  Caffeine and nicotine improve visual tracking by rats: a comparison with amphetamine, cocaine and apomorphine.

Authors:  J L Evenden; M Turpin; L Oliver; C Jennings
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effects of atropine on the repeated acquisition and performance of response sequences in humans.

Authors:  S T Higgins; B M Woodward; J E Henningfield
Journal:  J Exp Anal Behav       Date:  1989-01       Impact factor: 2.468

Review 9.  Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

Authors:  M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

10.  Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests.

Authors:  A Ennaceur; K Meliani
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.